E
EarLens
Medical device company specialized in manufacturing hearing aids
About EarLens
Earlens operates in the hearing aid market, offering a unique hearing solution that uses a small lens placed directly on the eardrum to vibrate and activate the natural hearing process. This method provides a more complete and natural sound compared to traditional hearing devices. The company's products are custom-fitted by physicians and audiologists, ensuring a comprehensive medical approach to hearing loss. Earlens serves clients who suffer from hearing loss and are looking for premium, personalized hearing care. The business model involves selling these advanced hearing solutions through select practices across the United States. Revenue is generated through the sale of the hearing devices and associated medical services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2005
- Headquarters
- Menlo Park, United States
- Employees
- 111
- Open positions
- 7
- Dealroom signal
- 37.8/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Rehabilitation, Hard Tech, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2024 | $19M | $75M | Undisclosed | ↗ |
| LATE VCOther financing | Aug 2021 | $21M | $85M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for EarLens is 2.1K monthly website visits, down 40% over the last three months. EarLens's team grew 6.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
NEA
Aisling Capital
Lightstone Ventures
Series B and later10 investors entered at this stage
Vertex Ventures HC
Medtronic
Cochlear- CLCRG LP
KCK- FVFar East Ventures
Windham Venture Partners
Andrew W. Mellon Foundation
Exor Ventures
SightLine Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EarLens on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EarLens’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







